GIORGI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 9.355
AS - Asia 5.321
EU - Europa 4.377
SA - Sud America 536
AF - Africa 199
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 19.808
Nazione #
US - Stati Uniti d'America 9.040
CN - Cina 1.722
IT - Italia 1.502
SG - Singapore 1.463
SE - Svezia 732
HK - Hong Kong 687
DE - Germania 573
BR - Brasile 479
VN - Vietnam 468
BG - Bulgaria 338
KR - Corea 321
GB - Regno Unito 295
CA - Canada 262
TR - Turchia 262
UA - Ucraina 194
FI - Finlandia 170
RU - Federazione Russa 161
IN - India 126
FR - Francia 99
CH - Svizzera 93
CI - Costa d'Avorio 77
GR - Grecia 56
JP - Giappone 50
BD - Bangladesh 44
AT - Austria 42
NG - Nigeria 38
BE - Belgio 31
IQ - Iraq 28
MX - Messico 28
IR - Iran 23
SN - Senegal 22
PL - Polonia 21
NL - Olanda 20
PK - Pakistan 19
ZA - Sudafrica 19
SA - Arabia Saudita 17
AR - Argentina 15
ID - Indonesia 15
MA - Marocco 12
UZ - Uzbekistan 12
VE - Venezuela 12
EC - Ecuador 10
ES - Italia 10
EU - Europa 9
AU - Australia 8
IE - Irlanda 7
KZ - Kazakistan 7
KE - Kenya 6
KG - Kirghizistan 6
LT - Lituania 6
NP - Nepal 6
TW - Taiwan 6
BJ - Benin 5
EG - Egitto 5
JO - Giordania 5
PH - Filippine 5
CL - Cile 4
CO - Colombia 4
CR - Costa Rica 4
DK - Danimarca 4
DZ - Algeria 4
JM - Giamaica 4
YE - Yemen 4
AL - Albania 3
BB - Barbados 3
BO - Bolivia 3
CG - Congo 3
EE - Estonia 3
ET - Etiopia 3
HU - Ungheria 3
MY - Malesia 3
OM - Oman 3
PE - Perù 3
PY - Paraguay 3
UY - Uruguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
CY - Cipro 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IL - Israele 2
IS - Islanda 2
KN - Saint Kitts e Nevis 2
LC - Santa Lucia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CD - Congo 1
FJ - Figi 1
GE - Georgia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
Totale 19.792
Città #
Woodbridge 1.171
Ann Arbor 1.007
Singapore 810
Ashburn 774
Houston 767
Milan 757
Chandler 700
Hong Kong 673
Santa Clara 557
Hefei 434
Fairfield 426
Dong Ket 391
Beijing 348
Sofia 338
Dallas 308
Seoul 291
Jacksonville 239
San Jose 237
Shanghai 229
Ottawa 205
Wilmington 202
Seattle 173
Cambridge 171
Izmir 171
New York 166
Chicago 162
Los Angeles 149
Boardman 133
Princeton 127
Lawrence 117
Medford 110
Nanjing 109
Bern 93
Abidjan 77
Des Moines 66
Jüchen 63
London 61
Alessandria 56
Rome 55
Serra 55
Dearborn 53
The Dalles 52
Buffalo 51
Florence 51
Columbus 49
Istanbul 46
Munich 42
Boulder 40
Bremen 40
Tokyo 40
Nanchang 38
Council Bluffs 37
Lagos 37
Vienna 36
Redondo Beach 35
Redwood City 33
Lancaster 32
Marseille 32
Ogden 32
São Paulo 32
Brussels 30
Hyderabad 29
Kocaeli 29
Sacile 29
Frankfurt am Main 27
Helsinki 27
Kunming 27
North York 26
Paris 26
San Diego 26
Shenyang 26
Düsseldorf 24
Fuzhou 23
Dakar 22
Pune 22
Guangzhou 21
Hebei 19
Grafing 18
Rio de Janeiro 18
Jiaxing 17
Tianjin 17
Verona 15
Baghdad 14
Belo Horizonte 14
Changsha 14
Falls Church 14
Hangzhou 14
Ho Chi Minh City 14
Dhaka 13
Warsaw 13
Nürnberg 12
Tabriz 12
Turku 12
Brasília 11
Jakarta 11
Norwalk 11
Johannesburg 10
Tashkent 10
Berlin 9
Brooklyn 9
Totale 14.521
Nome #
1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII 378
1,2,3-Triazolo[1,5-a][1,3]benzodiazepine a new heterocyclic system: Synthesis, benzodiazepine receptor binding and theoretical calculations 320
1,2,3 Triazolo[1,2-a]benzotriazoles or 2,3-Benzo-1,3a,6,6a-Tetraazapentalenes 312
1,2,3-Triazole[4,5-d]pyridazines II. New Derivatives Tested on the Adenosine Receptors 309
1,2,3-Triazolo[1,5-a][1,4]- and 1,2,3-Triazolo[1,5-a][1,5]benzodiazepine derivatives: synthesis and benzodiazepine receptor binding. 307
An 1,2,3-Triazole Derivative Bioisoster of a Potent in Vitro Prostaglandin Synthesis Inhibitor: Preparation and Biological Activity 302
1,2,3-triazolo [4,5-d] pyridazines-V. Preparation and adenosine receptor binding of new 4-amino derivatives. 297
N(6)-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: Synthesis and biological evaluation as allosteric modulators of A(2A) adenosine receptors 274
1,2,3-TRIAZOLO[4,5-e]-1,2,4-TRIAZOLO[3,4-c]PYRIMIDINES 269
N(6)-SUBSTITUTED 2-PHENYL-9-BENZYL-8-AZAADENINES - AFFINITY FOR ADENOSINE A(1)-RECEPTOR AND A(2)-RECEPTOR - A COMPARISON WITH 2-N-BUTYL ANALOGOUS DERIVATIVES .5. 266
1,2,3-TRIAZOLE[4,5-D]PYRIDAZINES .3. SYNTHESIS OF NEW 4-AMINO DERIVATIVES AND THEIR AFFINITY TOWARD ADENOSINE RECEPTORS 263
1,2,3-Triazolo[4,5-d]-1,2,4-triazolo[4,3-b]pyridazines 253
1,2,3-Triazole[4,5-d]pyridazines IV. Preparation and Adenosine Receptor Binding of New 4-and /or 7-Aminoderivatives 253
N(6)-SUBSTITUTED 2-N-BUTYL-9-BENZYL-8-AZAADENINES - AFFINITY FOR ADENOSINE A(1)-RECEPTOR AND A(2)-RECEPTOR .4. 251
1,2,3-Triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors 248
1,2,3-TRIAZOLO[4,5-D]PYRIDAZINES. PART VI. NEW 1-SUBSTITUTED-4-AMINO DERIVATIVES AND THEIR AFFINITY TOWARDS A1 AND A2 ADENOSINE RECEPTORS 245
1,2,3-triazolo[4,5-d]pyridazines - Part VI. New 1-substituted-4-amino derivatives and their affinity towards A(1) and A(2A) adenosine receptors 242
1,2,3-Triazolodiazepine I. Preparation and Benzodiazepine Receptor Binding of 1-Benzyl and 1-Phenethyl-1,2,3-Triazolo[4,5-d][1,4]diazepines 241
1,2,3-triazolo[1.5-a]quinazolines: synthesis, benzodiazepine receptor binding and theoretical calculations 236
N(6)-Substituted 2-n-Butyl-9-Benzyl-8-Azaadenines. Affinity for Adenosine A1 and A2 Receptors. IV 232
N(6)CYCLOALKYL-2-PHENYL-3-DEAZA-8-AZAADENINES: A NEW CLASS OF A1ADENOSINE RECEPTOR LIGANDS. A COMPARISON WITH THE CORRESPONDING ADENINES AND 8-AZAADENINES 221
"One Pot" Synthesis of 2-Substituted 9-(2'-Hydroxy-3'-aminopropyl)-8-azahypoxanthines and 8-Azaadenines [5-Substituted 3-(2'-Hydroxy-3'-aminopropyl)-7-amino and 7-hyroxy- 3H-1,2,3-triazolo[4,5-d]pyrimidines] 214
Synthesis of New 3-Benzyl-5-Phenyl-7-Alkylaminothiazolo[4,5-d]pyrimidine-2(3H)-Thiones.) 214
Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors 212
Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors 208
Novel 8-azapurine derivatives as ligands for A3 adenosine receptors 207
N-(9-Benzyl-2-phenyl-9H-8azapurin-6-yl)-amides: A new class of A1 adenosine receptor ligands 205
N(6) or N(9) Substituted 2-Phenyl-8-Azaadenines: Affinity for A1 Adenosine Receptors. VII 205
N(6)-substituted 2-phenyl-9-benzyl-8-azaadenines. Affinity for adenosine A1 and A2 receptors. A comparison with 2-N-butyl analogous derivatives.5. 205
N(9)-substituted 2-phenyl-N(6)-benzyl-8-azaadenines: A1 adenosine receptor affinity. A comparison with the corresponding N(6)-substituted 2-phenyl-N(9)-benzyl-8-azaadenines 205
Adenosine A1 modulators: a patent update (2008 to present) 205
N-[9-(ortho-Fluorobenzyl)-2-Phenyl-8-Azapurin-6-yl]-Amides as Potent and Selective Ligands for A1 Adenosine Receptors. 202
Structure-Activity Relationships on Purine and 2,3-Dihydropurine Derivatives as Antitubercular Agents: a Data Mining Approach 200
2-Fenyl-9-benzyl-6-arylamido-8-azapurines: new potent ligands of adenosine receptors 198
NEW 1,2,3-TRIAZOLO[1,5-a]QUINOXALINES: SYNTHESIS AND BINDING TO BENZODIAZEPINE AND ADENOSINE RECEPTORS. II 190
Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V 190
A QSAR study of A1adenosine receptor antagonists by a new neural network model 188
8-Azapurine nucleus: a versatile scaffold for different targets 187
2,9-Disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: Synthesis, biochemical and molecular modelling studies 177
In vitro Inhibitors of Prostaglandin Synthesis: (p-Thiosubstituted)-Benzyl Nitrogen Heterocycles 176
New amido derivatives as potential BKCa potassium channel activators. XI 176
Xanthine Oxidase (XO). 4(5)-Aminosubstituted-5(4)-Carboxyamido-1H-1,2,3-Triazoles: a New Class of Monocyclic Triazole Inhibitors 174
Prediction Model on Optionally Substituted 5,6-Membered Fused Ring Systems Containing C and/or N Atoms as Antifungal Agents Against Candida albicans Developed by Data Mining 174
Studies on 1,2,3-Triazole Derivatives as in vitro Inhibitors of Prostaglandine Synthesis 172
1,2,3-Trizoles[4,5-d]piridazines. Analogues of Prostaglandin Synthesis Inhibitors 169
Xanthine Oxidase Inhibition: Effect of a Linear Carboalkoxy Substituent on C(2) of the Nucleus of 8-Azahypoxanthine 168
Interaction of an improved model of human A1 adenosine receptor with ligands 168
Prediction model on optionalli substituted 5,6-membered fused ring systems containing C and/or N atoms as antifungal agents against Candida albicans developed by data mining 167
3-[(2-Ethoxyphenoxy)methyl]piperidine derivatives. Synthesis and antidepressant activity 167
New 4-(Benzotriazol-1-yl)-1,2,3-triazole derivatives 164
Antimicrobial properties of flavonoids. 164
Studies on Specific Inhibition of Benzodiazepine Receptor Binding by Some C-Benzoyl-1,2,3-triazole Derivatives 164
Evaluation of the Quantitative Contribution of a Phenyl Group on C(2) of 8-Azaadenosine to the Binding with Adenosine Deaminase: a New Synthesis of 8-Azaadenosine. XI. 163
QSAR study on purine and 2,3-dihydropurine analogues as antitubercular agents 162
5-(4'-SUBSTITUTED-2'-NITROANILINO)-1,2,3-TRIAZOLES AS NEW POTENTIAL POTASSIUM CHANNEL ACTIVATORS. I 161
Modification of the 1,2,3-Triazole Ring Present in an Effective in vitro Inhibitor of Prostaglandin Synthesis 160
A 3D model of human A1 adenosine receptor. An evaluation of the binding free energy with ligands 160
QSAR study on a novel series of 8-azaadenine analogues proposed as A1 adenosine receptor antagonists 159
Synthesis of N(6)-Substituted 2-Phenyl-8-Azaadenosines. Their Affinity for Adenosine A1 and A2 Receptors: a Comparison with the Corresponding 2-Phenyl-9-Benzyl-8-Azaadenines. 158
Structure-Activity Studies on a 1,2,3-Triazole Derivative, a Potent in vitro Inhibitor of Prostaglandin Synthesys: the Role of the Heterocyclic Ring 157
XANTHINE-OXIDASE (XO) - RELATIVE CONFIGURATION OF COMPLEXES FORMED BY THE ENZYME, 2-N-ALKYL-HYPOXANTHINE OR 8-N-ALKYL-HYPOXANTHINE AND 2-N-ALKYL-8-AZAHYPOXANTHINES .12. 157
1-(1,2,3-TRIAZOL-4-YL)-BENZIMIDAZOLONES, A NEW SERIES OF HETEROCYCLIC DERIVATIVES 156
Introduction of a hydroxy function on N6 8-azaadenine substituents to improve the solubility and the effectiveness of antagonists towards A1 adenosine receptors 152
An initial comparison of the content of bitter substances in Cynara Scolymus L. plants obtained from rooted of shoots and micropropagation 152
Synthesis of New 2-Substituted 9-?-D-Ribofuranosyl-8-Azahypoxanthine 151
TRIAZOLYLBENZIMIDAZOLTHIONES AND DERIVATIVES OF THE NEW 1,2,3-TRIAZOLO[1,5-A][1,3,5]BENZOTRIAZEPINE HETEROCYCLE 151
Bioisosterism, enantioselectivity and molecular modeling of new effective N6- and/or N(9)-substituted 2-phenyl adenines and 8-aza analogs: different binding modes to A1 adenosine receptors 151
ERYTHRO AND THREO 2-HYDROXYNONYL SUBSTITUTED 2-PHENYLADENINES AND 2-PHENYL-8-AZAADENINES: LIGANDS FOR A1 ADENOSINE RECEPTORS AND ADENOSINE DEAMINASE 149
QSAR Studies on Purine and 2,3-Dihydropurine Analogues as Antitubercular Agents 148
1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII. 148
Synthesis of New 1,2,3-triazolo[1,2-a]benzotriazole derivatives or substituted 2,3-benzo-1,3a,6,6a-tetraazapentalenes. II” 145
Synthesis of new 2-phenyladenines and 2-phenylpteridines and biological evaluation as adenosine receptor ligands 144
Synthesis and functional evaluation of Adenosine A2A receptor ligand 141
An 1,2,3,Triazole Derivatives Bioisoster of a Potent in vitro Prostaglandin Synthesis Inhibitor: Preparation and Biological Activity 140
A Method for the Synthesis of Racemic and Optically Active 2-Substituted 9-(2',3'-Dihidroxypropyl)-8-Azahypoxanthines and 8-Azaadenines 140
2-ALKYLOXYALKYLTHIOHYPOXANTHINES AS NEW POTENT INHIBITORS OF XANTHINE OXIDASE 139
THERAPEUTIC POTENTIAL OF A1 ADENOSINE RECEPTOR LIGANDS: A SURVEY OF RECENT PATENT LITERATURE 139
Xanthine Oxidase (XO): Relative Configuration of Complexes Formed by the Enzyme, 2- or 8-n-Alkyl-hypoxanthines and 2-n-Alkyl-8-azahypoxanthines. XII 138
New Chiral Inhibitors of Induced Platelet Aggregation: the Enantiomeric Specificity of (R)- and (S)-Methyl and Ethyl Esters of 1-{p-[(1-Hydroxycarbonyl)-ethyloxy]-benzyl}-1H-1,2,3-triazole as a Tool for Determining their Biological Target. 138
SOME STRUCTURAL CHANGES ON TRIAZOLYL-BENZOTRIAZOLES AND TRIAZOLYL-BENZIMIDAZOLONES AS POTENTIAL POTASSIUM CHANNEL ACTIVATORS. III 138
Synthesis and ADA Inhibitory Activity of New 2-Aryl-8-Azaadenosines 135
Synthesis and Biological Evaluation of New Imidazole, Pyrimidine and Purine Derivatives and Analogs as Inhibitors of Xanthine Oxidase 131
Interactions of an improved model of the the Human A1 Adenosine Receptor with Ligands 130
THE NEW DEGREE IN TECHICHE ERBORISTICHE (HERBAL TECHNOLOGY) 130
Xanthine Oxidase (XO). Synthesis of 4(5)-Carbxyamido-5(4)-aminoalkanoyl)amino-1,2,3-triazoles and Their Cyclization to 8-Azahypoxanthines. Evaluation for Inhibition of XO. 129
Evaluation of new synthesized “adenine derivatives” molecules as cytokinin-like compounds . 129
Structural modifications of benzanilide derivatives, effective potassium channel openers. X 128
Steroeselectivity as an evidence for a double insertion of Antagonists within A1 Adenosine Receptors 124
SUBSTITUTED 1,2,3-TRIAZOLO[1,5-A]QUINAZOLINES: SYNTHESIS AND BINDING TO BENZODIAZEPINE AND ADENOSINE RECEPTORS 124
NEW 1,2,3-TRIAZOLO[4,5-E]1,2,3-TRIAZOLO[4,3-C]PYRIMIDINE DERIVATIVES.II 123
Chemistry of the Dihydrothiazine Ring Moiety of Cephalosporins. A Route to 3-Formoxymethyl-3-Cephem Derivatives 122
Synthesis of analogs of (±)-EHNA as potent inhibitors of ADA 121
Heterocyclic analogs of benzanilide derivatives as potassium channel activators. IX 121
NEW N6-OR N(9)-HYDROXYALKYL SUBSTITUTED 8-AZAADENINES OR ADENINES AS AFFECTIVE A1 ADENOSINE RECEPTOR LIGANDS 120
Alimentazione e qualità della vita 120
NEW 5-SUBSTITUTED-1-(2-HYDROXYBENZOYL)-BENZOTRIAZOLES, POTASSIUM CHANNELS ACTIVATORS. IV 118
A 3D Model of the Human A1 Adenosine Receptor. An Evaluation of the Binding Free-Energy with Ligands 118
1,5-Diarylsubstituted 1,2,3-triazoles as potential potassium channels activators. VI. 117
Triazolyl-benzimidazolones and triazolyl-benzotriazoles: new potential potassium channel activators. II 114
Interconversion of the thiazine and thiazolidine system of β -lactam antibiotics. Electrochemical cleavage of Kamiya's disulfide promoted by bromide ion 110
Totale 18.195
Categoria #
all - tutte 50.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.183


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021762 0 0 0 0 0 0 54 72 54 87 46 449
2021/20221.459 16 119 20 110 259 198 15 100 87 14 91 430
2022/20231.873 254 240 118 208 217 239 30 138 304 7 101 17
2023/20242.134 319 238 365 218 313 224 29 56 25 58 44 245
2024/20254.036 46 146 41 212 429 407 286 229 355 455 528 902
2025/20263.059 481 674 518 258 407 395 326 0 0 0 0 0
Totale 19.874